Adagene Inc. (ADAG) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Adagene Inc.

    NASDAQ: ADAG · Real-Time Price · USD
    2.00
    0.04 (2.04%)
    At close: Sep 29, 2025, 3:59 PM
    2.00
    0.00%
    After-hours: Sep 29, 2025, 07:48 PM EDT

    Adagene Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 103.2K 18.11M 9.29M 10.18M
    Cost of Revenue
    		 n/a n/a n/a n/a
    Gross Profit
    		 -823.04K 18.11M 9.29M 10.18M
    Operating Income
    		 -35.95M -23.72M -83.92M -72.36M
    Interest Income
    		 3.8M 4.28M 377.5K 76.17K
    Pretax Income
    		 -33.44M -17.25M -79.51M -71.48M
    Net Income
    		 -33.42M -18.95M -79.97M -73.18M
    Selling & General & Admin
    		 7.27M 8.67M 11.87M 14.44M
    Research & Development
    		 28.78M 36.64M 81.34M 68.1M
    Other Expenses
    		 n/a -3.48M n/a n/a
    Operating Expenses
    		 36.05M 41.83M 93.21M 82.54M
    Interest Expense
    		 851.87K 1.11M 693.32K 363.76K
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 36.05M 41.83M 93.21M 82.54M
    Income Tax Expense
    		 -17.55K 1.69M 459.06K 1.7M
    Shares Outstanding (Basic)
    		 36.02M 34.64M 34.65M 32.02M
    Shares Outstanding (Diluted)
    		 36.02M 35.03M 34.65M 32.02M
    EPS (Basic)
    		 -0.95 -0.55 -2.31 -2.29
    EPS (Diluted)
    		 -0.95 -0.54 -2.31 -2.29
    EBITDA
    		 -31.66M -14.95M -77.39M -69.99M
    EBIT
    		 -32.59M -16.15M -78.82M -71.11M
    Depreciation & Amortization
    		 926.25K 1.21M 1.43M 1.13M

    Add to Watchlist